secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001641172-25-022258
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance
--------------------------------------------------------------------------------

- Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).
- Adjusted EBITDA $7.1M (+223% YoY); generated >$8M operating cash flow.
- Paid down $2.1M senior debt, ended quarter with $36.2M cash; fully repaid all senior debt post-quarter.
- Launched nationwide behavioral health offering, acquired virtual women's health brand, upgraded LifeMD+ membership.
- Revised FY2025 guidance downward due to temporary challenges at Rex MD, still expects strong YoY growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000164117225022258/0001641172-25-022258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000164117225022258/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer